RCUS - Arcus Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.17
DETAILS
HIGH:
$47.00
LOW:
$22.00
MEDIAN:
$30.00
CONSENSUS:
$31.17
UPSIDE:
33.03%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 96.0% |
| EBIT Margin | -139.7% |
| EBITDA Margin | -135.6% |
| Operating Margin | -156.3% |
| Pretax Margin | -142.9% |
| Cont. Ops Margin | -142.9% |
| Net Margin | -142.9% |
| Bottom Line Margin | -142.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 4.36 |
| Quick Ratio | 4.36 |
| Solvency Ratio | -0.675 |
| Cash Ratio | 0.96 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | -1.52 |
| Forward PEG | -1.52 |
| Price/Book | 4.06 |
| Price/Sales | 10.36 |
| Price/FCF | -5.29 |
| Price/Op Cash Flow | -5.31 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0869 |
| Debt/Equity | 0.1569 |
| Debt/Capital | 0.1356 |
| Long-Term Debt/Capital | 0.1356 |
| Financial Leverage | 1.81 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.32 |
| Operating Cash Flow Ratio | -2.087 |
| Operating Cash Flow/Sales | -195.1% |
| Free Cash Flow/Operating Cash Flow | 100.4% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -41.88 |
| Interest Coverage | -48.2500 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -4.87 |
| Capital Expenditure Coverage | -241.00 |
| Dividend + Capital Expenditure Coverage | -241.00 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.30 |
| EPS | -3.287 |
| Debt/Share | 0.9963 |
| Cash/Share | 9.13 |
| Book Value/Share | 5.88 |
| Tangible BV/Share | 5.88 |
| Equity/Share | 5.88 |
| Operating Cash Flow/Share | -4.488 |
| Capital Expenditure/Share | 0.019 |
| FCF/Share | -4.507 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.915 |
| Price/Fair Value | 4.06 |
| Debt/Market Cap | 0.0387 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -7.27 |